G1 Therapeutics competitors

G1 Therapeutics Competitors include PDL BioPharma, GTx, Burzynski Research Institute and Alpine Immune Sciences.
Add company...
G1 Therapeutics
G1 Therapeutics
G1 is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of cancer.
PDL BioPharma
PDL BioPharma
PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities.
GTx
GTx
GTx, Inc is a pharmaceutical company and developer of drugs that utilize hormonal pathways.
Burzynski Research Institute
Burzynski Research Institute
Burzynski Research Institute is primarily engaged as a research and development facility for Antineoplaston drugs being tested for the use in the treatment of cancer.
Alpine Immune Sciences
Alpine Immune Sciences
Modern therapies targeting the immune synapse.
Founding Date
Founding Date
2008
Founding Date
1986
Founding Date
1997
Founding Date
1984
Founding Date
2015
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Durham, US HQ
Locations
Incline Village, US HQ
Locations
Memphis, US HQ
Locations
Houston, US HQ
Stafford, US
Locations
Seattle, US HQ
Employees
Employees
4416% increase
Employees
11
Employees
274% increase
Employees
2
Employees
N/A
Valuation ($)
Valuation ($)
1.3 b
Valuation ($)
433.5 m
Valuation ($)
32.5 m
Valuation ($)
4 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$320.1m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$1.7m (FY, 2017)
Net income
Net income
($60.1m) (FY, 2017)
Net income
N/A
Net income
($30.4m) (FY, 2017)
Net income
($1.6m) (FY, 2018)
Net income
($7.8m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 92.5m
Total funding raised
N/A
Total funding raised
$ 64.7m
Total funding raised
N/A
Total funding raised
$ 49.3m
For sources of this data, please see the company profileDownload Excel

View company profiles

PDL BioPharma
HQ
Incline Village, US
Employees
11

PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities.

View company
GTx
HQ
Memphis, US
Employees
27↑ 4% increase

GTx, Inc is a pharmaceutical company and developer of drugs that utilize hormonal pathways.

View company
Burzynski Research Institute
HQ
Houston, US
Employees
2

Burzynski Research Institute is primarily engaged as a research and development facility for Antineoplaston drugs being tested for the use in the treatment of cancer.

View company
Alpine Immune Sciences
HQ
Seattle, US

Modern therapies targeting the immune synapse.

View company